Diabetic Retinopathy (DR)

DBCOND0118126Cardiovascular DiseasesDigestive System Diseases

Diabetic Retinopathy (DR) is the indication for 2 drugs in DrugBank. It is covered by 2 curated, structured indications.

Also known as
Diabetic Retinopathy · Retinopathy, Diabetic · DR · Diabetic Retinopathy, DR
Classified under
Indicated drugs

Resolves to

Vocabularies
MeSHM0006163SNOMED CT141196007MedDRA10012689UMLSC0011884

What you can answer from here — as of October 22, 2026

2Indicated drugsWith each drug's targets and mechanism
Listed above
2Structured indicationsPopulation, line of therapy, route and combination as fields, not prose
Sign in
298Clinical trialsPhase, status and sponsor resolved per trial
Sign in
4Drugs reporting it as an adverse effectWith incidence where the label states it
Sign in

Which approved drugs for Diabetic Retinopathy (DR) share a target, and which companies have late-stage candidates against it?

Answer this in Biopharma OSSign in to your account

Create a free account or log in to explore the full data card.

Create Account
Log InPaid Account Log In